Fairfield, Bush & Co’s Medtronic MDT Stock Holding History

Fairfield, Bush & Co’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-316	Closed	-$26K	–	323
2023 Q4	$26K	Buy	+316	New	+$24.1K	0.02%	230
2023 Q3	–	Sell	-367	Closed	-$32.3K	–	340
2023 Q2	$32.3K	Buy	+367	New	+$31.6K	0.01%	241
2022 Q3	–	Sell	-394	Closed	-$35K	–	312
2022 Q2	$35K	Buy	+394	New	+$39.9K	0.02%	220
2018 Q2	–	Sell	-100	Closed	-$8K	–	175
2018 Q1	$8K	Buy	+100	New	+$8.25K	﹤0.01%	188
2013 Q4	–	Sell	-2,400	Closed	-$127K	–	199
2013 Q3	$127K	Hold	2,400	–	–	0.04%	169
2013 Q2	$124K	Buy	+2,400	New	+$119K	0.06%	153

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fairfield, Bush & Co's MDT Position: Q1 2024 in Review

Fairfield, Bush & Co sold out of Medtronic (MDT) in Q1 2024, closing a stake of 316 shares — an estimated $26K sold.

Fairfield, Bush & Co first reported a position in MDT in Q2 2013 and held it in 6 quarters. The position peaked at $127K in Q3 2013. 2,081 funds tracked by Wall St. Rank hold MDT as of Q1 2024.

Fairfield, Bush & Co reported no remaining Medtronic position as of Q1 2024 after selling out during the quarter.
Fairfield, Bush & Co sold 316 Medtronic shares in Q1 2024, an estimated $26K.
Fairfield, Bush & Co first reported a position in Medtronic in Q2 2013 and held it in 6 quarters.
Fairfield, Bush & Co's Medtronic position peaked at $127K in Q3 2013.
2,081 funds tracked by Wall St. Rank held Medtronic as of Q1 2024.

Based on Fairfield, Bush & Co's 13F filing for Q1 2024, filed 15 May 2024.